Small-cell carcinoma of the bladder (SCCB) is a rare, highly aggressive, neoplasm. We retrospectively analyzed the Surveillance, Epidemiology, and End Results (SEER) database to investigate the impact of chemotherapy, surgery, and radiotherapy on overall survival (OS) of patients with non-metastatic SCCB.
Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study
Cattrini, Carlo;Cerbone, Luigi;Rubagotti, Alessandra;Zinoli, Linda;Latocca, Maria Maddalena;Messina, Carlo;Zanardi, Elisa;Boccardo, Francesco
2019-01-01
Abstract
Small-cell carcinoma of the bladder (SCCB) is a rare, highly aggressive, neoplasm. We retrospectively analyzed the Surveillance, Epidemiology, and End Results (SEER) database to investigate the impact of chemotherapy, surgery, and radiotherapy on overall survival (OS) of patients with non-metastatic SCCB.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
prognostic1-s2.0-S1558767318306591-main(1).pdf
accesso chiuso
Tipologia:
Documento in versione editoriale
Dimensione
1.41 MB
Formato
Adobe PDF
|
1.41 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
